Miracle dental care and implant center, Damak

 Name of Dental Clinic: Miracle dental care and implant center

Address (Full): Falgunanda chowk,Damak

Year of Establishment: 2079

Name of the chief Dental Surgeon: Dr Mira Singh

CONTACT NUMBER: 9862967474

NMC Number of Dental Surgeon: 17479

CLICK HERE TO VIEW ALL DENTAL CLINICS OF KOSHI PROVINCE

Transform Your Smile with Damak's Specialist Orthodontist!

 Are you hiding your smile because of crooked, crowded, or misaligned teeth? A healthy, confident smile can change your life—and getting there is easier than you think.

Meet Dr. Raman Dhungel, a specialized Orthodontist providing premier orthodontic and dentofacial orthopedic care right here in Damak, Jhapa. With both his BDS and MDS degrees completed at the prestigious B.P. Koirala Institute of Health Sciences (BPKIHS, Dharan), Dr. Dhungel brings top-tier academic excellence and advanced clinical precision to Eastern Nepal.

Whether you need traditional braces, clear aligners, or early functional appliance therapy for your child, Dr. Dhungel uses evidence-based, scientifically proven techniques to design a treatment plan tailored specifically to your facial structure and dental needs.

🌟 Why Choose Dr. Raman Dhungel?

• Specialist Expertise: Master of Dental Surgery (MDS) in Orthodontics & Dentofacial Orthopedics from BPKIHS.

• Comprehensive Care: From metal and ceramic braces to advanced dentofacial growth modifications.

• Meticulous Precision: Reliable, detail-oriented treatments focused on both aesthetics and long-term oral health.

• Convenient Location: Expert specialty care available locally in Damak, Jhapa.

Don’t wait to get the smile you’ve always wanted. Let an expert guide your orthodontic journey!

📍 Location: Damak, Jhapa 📞 Book your consultation today via WhatsApp: 9803027654

Orthodontic Treatment at Damak Hospital by Dr. Raman Dhungel

 

Drug of choice for focal seizure is:

 # Drug of choice for focal seizure is:

A. Phenytoin

B. Gabapentin

C. Lorazepam

D. Levetiracetam

The correct answer is D. Levetiracetam.

Levetiracetam is the drug of choice for focal (partial) onset seizures.

Current clinical practice and guidelines (including ILAE and NICE) prefer Levetiracetam (or Lamotrigine) as a first-line monotherapy due to its broad-spectrum efficacy, rapid onset, linear pharmacokinetics, minimal drug interactions, and superior safety profile compared to older agents.

Breakdown of the options:

• Levetiracetam: First-line drug of choice for newly diagnosed focal seizures (both with and without focal-to-bilateral tonic-clonic evolution).

• Phenytoin: Classic first-line agent for focal seizures, but largely replaced by newer anticonvulsants due to zero-order kinetics, severe drug-drug interactions, and adverse effects (e.g., gingival enlargement, nystagmus, ataxia).

• Gabapentin: Used primarily as adjunctive (add-on) therapy for focal seizures, or for neuropathic pain.

• Lorazepam: First-line drug of choice for acute emergency management of status epilepticus, not long-term monotherapy.